Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000950170-24-001054

Chief Financial Officer sold 15,000 shares at $77.07 ($1,156,050)

  • Chief Financial Officer acquired 15,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gordon Stephen Chief Financial Officer 2024-01-02 Option exercise 10b5-1 +15,000 $13.28 $199,200 28,075 D: show line 1 in the form
Gordon Stephen Chief Financial Officer 2024-01-02 Sale 10b5-1 −15,000 $77.07 $1,156,050 13,075 D: show line 2 in the form
Open-market sales · 15,000 sh · avg $77.07 · $1,156,050

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gordon Stephen Chief Financial Officer 2024-01-02 Option exercise · Stock Option (Right to Buy) 10b5-1 −15,000 37,000 D: show line 3 in the form
Loading xslF345X05/ownership.xml…